Sugar Maple Asset Management »

Crispr Therapeutics shares owned by Sugar Maple Asset Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Sugar Maple Asset Management from 13F filings

Historical chart of Sugar Maple Asset Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Sugar Maple Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Sugar Maple Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.5k 39 39.36

More positions owned by Sugar Maple Asset Management

Abbvie (ABBV)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr TRS FLT RT BD (TFLO)
Ishares Tr Core S&p500 Etf (IVV)
Abbott Laboratories (ABT)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Silver Tr Ishares (SLV)
Vaneck Etf Trust Clo Etf (CLOI)
T Rowe Price Etf Cap Appreciation (TCAF)
Ishares Tr Msci Usa Min Vol (USMV)
Vanguard Specialized Funds Div App Etf (VIG)
Fidelity Covington Trust Divid Etf Risi (FDRR)
Pacer Fds Tr Swan Sos Fd Of (PSFF)
Spdr Series Trust S&p Divid Etf (SDY)

View all positions for Sugar Maple Asset Management

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics